The 5th Subcommittee on Pharmaceuticals Development

Press Releaseopen close

Agenda

1. Exchange of Opinions on Drug Development
   • Academia Drug Discovery -From the Viewpoint of Intellectual Property-
     (Dr. Jun Utsumi, Senior Intellectual Property Consultant, Department of Intellectual Property, Japan Agency for Medical Research and Development (AMED))
   • Academia Drug Discovery -What We Are Expecting, Challenges we face-
     (Dr. Kentaro Yoshimatsu, Senior Scientific Advisor, Eisai Co., Ltd.)
2. Points to Consider and Future Plan

List of Handouts

• Document 1 Points to Consider on Report and Writing Leaders in Charge (Draft)
• Document 2 Lecture Materials (Dr. Jun Utsumi)
• Document 3 Lecture Materials (Dr. Kentaro Yoshimatsu)
• Ref.1 Glossary